Tepotinib in Non–Small-Cell Lung Cancer with MET Exon 14 Skipping Mutations
Paik, Paul K, Felip, Enriqueta, Veillon, Remi, Sakai, Hiroshi, Cortot, Alexis B, Garassino, Marina C, Mazieres, Julien, Viteri, Santiago, Senellart, Helene, Van Meerbeeck, Jan, Raskin, Jo, Reinmuth, Niels, Conte, Pierfranco, Kowalski, Dariusz, Cho, Byoung Chul, Patel, Jyoti D, Horn, Leora, Griesinger, Frank, Han, Ji-Youn, Kim, Young-Chul, Chang, Gee-Chen, Tsai, Chen-Liang, Yang, James C.-H, Chen, Yuh-Min, Smit, Egbert F, van der Wekken, Anthonie J, Kato, Terufumi, Juraeva, Dilafruz, Stroh, Christopher, Bruns, Rolf, Straub, Josef, Johne, Andreas, Scheele, Jürgen, Heymach, John V, Le, Xiuning
Published in The New England journal of medicine (03.09.2020)
Published in The New England journal of medicine (03.09.2020)
Get full text
Journal Article
First-Line Afatinib versus Chemotherapy in Patients with Non–Small Cell Lung Cancer and Common Epidermal Growth Factor Receptor Gene Mutations and Brain Metastases
Schuler, Martin, Wu, Yi-Long, Hirsh, Vera, O’Byrne, Kenneth, Yamamoto, Nobuyuki, Mok, Tony, Popat, Sanjay, Sequist, Lecia V., Massey, Dan, Zazulina, Victoria, Yang, James C.-H.
Published in Journal of thoracic oncology (01.03.2016)
Published in Journal of thoracic oncology (01.03.2016)
Get full text
Journal Article
Efficacy of alectinib in central nervous system metastases in crizotinib-resistant ALK -positive non–small-cell lung cancer: Comparison of RECIST 1.1 and RANO-HGG criteria
Gandhi, Leena, Ignatius Ou, Sai-Hong, Shaw, Alice T, Barlesi, Fabrice, Dingemans, Anne-Marie C, Kim, Dong-Wan, Camidge, D. Ross, Hughes, Brett G.M, Yang, James C.-H, de Castro, Javier, Crino, Lucio, Léna, Hervé, Do, Pascal, Golding, Sophie, Bordogna, Walter, Zeaiter, Ali, Kotb, Ahmed, Gadgeel, Shirish
Published in European journal of cancer (1990) (01.09.2017)
Published in European journal of cancer (1990) (01.09.2017)
Get full text
Journal Article
Rationale and design of ON-TRK: a novel prospective non-interventional study in patients with TRK fusion cancer treated with larotrectinib
Yang, James C H, Brose, Marcia S, Castro, Gilberto, Kim, Edward S, Lassen, Ulrik N, Leyvraz, Serge, Pappo, Alberto, López-Ríos, Fernando, Reeves, John A, Fellous, Marc, Penault-Llorca, Frédérique, Rudzinski, Erin R, Tabatabai, Ghazaleh, Vassal, Gilles, Drilon, Alexander, Trent, Jonathan
Published in BMC cancer (07.06.2022)
Published in BMC cancer (07.06.2022)
Get full text
Journal Article
Osimertinib As First-Line Treatment of EGFR Mutation-Positive Advanced Non-Small-Cell Lung Cancer
Ramalingam, Suresh S, Yang, James C-H, Lee, Chee Khoon, Kurata, Takayasu, Kim, Dong-Wan, John, Thomas, Nogami, Naoyuki, Ohe, Yuichiro, Mann, Helen, Rukazenkov, Yuri, Ghiorghiu, Serban, Stetson, Daniel, Markovets, Aleksandra, Barrett, J Carl, Thress, Kenneth S, Jänne, Pasi A
Published in Journal of clinical oncology (20.03.2018)
Published in Journal of clinical oncology (20.03.2018)
Get full text
Journal Article
Brigatinib Versus Crizotinib in Advanced ALK Inhibitor-Naive ALK-Positive Non-Small Cell Lung Cancer: Second Interim Analysis of the Phase III ALTA-1L Trial
Camidge, D Ross, Kim, Hye Ryun, Ahn, Myung-Ju, Yang, James C H, Han, Ji-Youn, Hochmair, Maximilian J, Lee, Ki Hyeong, Delmonte, Angelo, García Campelo, Maria Rosario, Kim, Dong-Wan, Griesinger, Frank, Felip, Enriqueta, Califano, Raffaele, Spira, Alexander, Gettinger, Scott N, Tiseo, Marcello, Lin, Huamao M, Gupta, Neeraj, Hanley, Michael J, Ni, Quanhong, Zhang, Pingkuan, Popat, Sanjay
Published in Journal of clinical oncology (01.11.2020)
Published in Journal of clinical oncology (01.11.2020)
Get full text
Journal Article
Tepotinib Treatment in Patients With MET Exon 14-Skipping Non-Small Cell Lung Cancer: Long-term Follow-up of the VISION Phase 2 Nonrandomized Clinical Trial
Mazieres, Julien, Paik, Paul K, Garassino, Marina C, Le, Xiuning, Sakai, Hiroshi, Veillon, Remi, Smit, Egbert F, Cortot, Alexis B, Raskin, Jo, Viteri, Santiago, Wu, Yi-Long, Yang, James C H, Ahn, Myung-Ju, Ma, Rui, Zhao, Jun, O'Brate, Aurora, Berghoff, Karin, Bruns, Rolf, Otto, Gordon, Johne, Andreas, Felip, Enriqueta, Thomas, Michael
Published in JAMA oncology (01.09.2023)
Published in JAMA oncology (01.09.2023)
Get more information
Journal Article
Nazartinib for treatment-naive EGFR-mutant non−small cell lung cancer: Results of a phase 2, single-arm, open-label study
Tan, Daniel S.W., Kim, Sang-We, Ponce Aix, Santiago, Sequist, Lecia V., Smit, Egbert F., Yang, James C.H., Hida, Toyoaki, Toyozawa, Ryo, Felip, Enriqueta, Wolf, Juergen, Grohé, Christian, Leighl, Natasha B., Riely, Gregory, Cui, Xiaoming, Zou, Mike, Ghebremariam, Samson, O'Sullivan-Djentuh, Leslie, Belli, Riccardo, Giovannini, Monica, Kim, Dong-Wan
Published in European journal of cancer (1990) (01.09.2022)
Published in European journal of cancer (1990) (01.09.2022)
Get full text
Journal Article
Tumor response and health-related quality of life in clinically selected patients from Asia with advanced non-small-cell lung cancer treated with first-line gefitinib: Post hoc analyses from the IPASS study
Wu, Yi-Long, Fukuoka, Masahiro, Mok, Tony S.K, Saijo, Nagahiro, Thongprasert, Sumitra, Yang, James C.H, Chu, Da-Tong, Yang, Jin-Ji, Rukazenkov, Yuri
Published in Lung cancer (Amsterdam, Netherlands) (01.08.2013)
Published in Lung cancer (Amsterdam, Netherlands) (01.08.2013)
Get full text
Journal Article
Phase Ib/II study of ceritinib in combination with ribociclib in patients with ALK-rearranged non–small cell lung cancer
Santoro, Armando, Su, Wu-Chou, Navarro, Alejandro, Simonelli, Matteo, CH Yang, James, Ardizzoni, Andrea, Barlesi, Fabrice, Hyoung Kang, Jin, DiDominick, Sarah, Abdelhady, Ahmed, Chen, Xueying, Stammberger, Uz, Felip, Enriqueta
Published in Lung cancer (Amsterdam, Netherlands) (01.04.2022)
Published in Lung cancer (Amsterdam, Netherlands) (01.04.2022)
Get full text
Journal Article
Osimertinib in Patients With Epidermal Growth Factor Receptor Mutation-Positive Non-Small-Cell Lung Cancer and Leptomeningeal Metastases: The BLOOM Study
Yang, James C H, Kim, Sang-We, Kim, Dong-Wan, Lee, Jong-Seok, Cho, Byoung Chul, Ahn, Jin-Seok, Lee, Dae H, Kim, Tae Min, Goldman, Jonathan W, Natale, Ronald B, Brown, Andrew P, Collins, Barbara, Chmielecki, Juliann, Vishwanathan, Karthick, Mendoza-Naranjo, Ariadna, Ahn, Myung-Ju
Published in Journal of clinical oncology (20.02.2020)
Published in Journal of clinical oncology (20.02.2020)
Get full text
Journal Article
Clinical activity of afatinib in patients with advanced non-small-cell lung cancer harbouring uncommon EGFR mutations: a combined post-hoc analysis of LUX-Lung 2, LUX-Lung 3, and LUX-Lung 6
Yang, James C-H, Prof, Sequist, Lecia V, MD, Geater, Sarayut Lucien, MD, Tsai, Chun-Ming, Prof, Mok, Tony Shu Kam, Prof, Schuler, Martin, Prof, Yamamoto, Nobuyuki, Prof, Yu, Chong-Jen, Prof, Ou, Sai-Hong I, MD, Zhou, Caicun, Prof, Massey, Daniel, MSc, Zazulina, Victoria, MD, Wu, Yi-Long, Prof
Published in The lancet oncology (01.07.2015)
Published in The lancet oncology (01.07.2015)
Get full text
Journal Article
Plasma ctDNA Analysis for Detection of the EGFR T790M Mutation in Patients with Advanced Non–Small Cell Lung Cancer
Jenkins, Suzanne, Yang, James C-H., Ramalingam, Suresh S., Yu, Karen, Patel, Sabina, Weston, Susie, Hodge, Rachel, Cantarini, Mireille, Jänne, Pasi A., Mitsudomi, Tetsuya, Goss, Glenwood D.
Published in Journal of thoracic oncology (01.07.2017)
Published in Journal of thoracic oncology (01.07.2017)
Get full text
Journal Article
Brigatinib Versus Crizotinib in ALK Inhibitor–Naive Advanced ALK-Positive NSCLC: Final Results of Phase 3 ALTA-1L Trial
Camidge, D. Ross, Kim, Hye Ryun, Ahn, Myung-Ju, Yang, James C.H., Han, Ji-Youn, Hochmair, Maximilian J., Lee, Ki Hyeong, Delmonte, Angelo, Garcia Campelo, Maria Rosario, Kim, Dong-Wan, Griesinger, Frank, Felip, Enriqueta, Califano, Raffaele, Spira, Alexander I., Gettinger, Scott N., Tiseo, Marcello, Lin, Huamao M., Liu, Yuyin, Vranceanu, Florin, Niu, Huifeng, Zhang, Pingkuan, Popat, Sanjay
Published in Journal of thoracic oncology (01.12.2021)
Published in Journal of thoracic oncology (01.12.2021)
Get full text
Journal Article
Osimertinib with or without Chemotherapy in EGFR -Mutated Advanced NSCLC
Planchard, David, Jänne, Pasi A, Cheng, Ying, Yang, James C-H, Yanagitani, Noriko, Kim, Sang-We, Sugawara, Shunichi, Yu, Yan, Fan, Yun, Geater, Sarayut L, Laktionov, Konstantin, Lee, Chee K, Valdiviezo, Natalia, Ahmed, Samreen, Maurel, Jean-Marc, Andrasina, Igor, Goldman, Jonathan, Ghiorghiu, Dana, Rukazenkov, Yuri, Todd, Alex, Kobayashi, Kunihiko
Published in The New England journal of medicine (23.11.2023)
Published in The New England journal of medicine (23.11.2023)
Get full text
Journal Article
Osimertinib in patients with T790M mutation‐positive, advanced non–small cell lung cancer: Long‐term follow‐up from a pooled analysis of 2 phase 2 studies
Ahn, Myung‐Ju, Tsai, Chun‐Ming, Shepherd, Frances A., Bazhenova, Lyudmila, Sequist, Lecia V., Hida, Toyoaki, Yang, James C. H., Ramalingam, Suresh S., Mitsudomi, Tetsuya, Jänne, Pasi A., Mann, Helen, Cantarini, Mireille, Goss, Glenwood
Published in Cancer (15.03.2019)
Published in Cancer (15.03.2019)
Get full text
Journal Article